BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Nov. 6, 2007
View Archived Issues
Deaths End Novacea's Prostate Cancer Trial
Novacea Inc. and its partner Schering-Plough Corp. halted a Phase III trial of an investigational prostate cancer treatment because of a higher rate of deaths in patients receiving the drug, the firms said Monday. (BioWorld Today)
Read More
Lead Therapeutics' Series A: $17M For Research In China
Read More
Immune Proteins 'Moonlight' In Brain Development, Repair
Read More
Favrille Adding $21M Via Direct Offering For FavId
Read More
Liver Disease Roundup
Read More
Other News To Note
Read More
American Heart Assoc. Roundup
Read More
Clinic Roundup
Read More